University of Wisconsin School of Medicine & Public Health, Center for Tobacco Research and Intervention, Madison, WI, USA.
Aniwahya Consulting Services, Sun Prairie, WI, USA.
J Alzheimers Dis. 2023;91(1):183-189. doi: 10.3233/JAD-220393.
Individuals with Alzheimer's disease and related dementias (ADRD) accrue higher healthcare utilization costs than peers without ADRD, but incremental costs of ADRD among American Indians/Alaska Natives (AI/AN) is unknown. State-wide paid electronic health record data were retrospectively analyzed using percentile-based bootstrapped 95% confidence intervals of the weighted mean difference of total 5-year billed costs to compare total accrued for non-Tribal and Indian Health Service utilization costs among Medicaid and state program eligible AI/AN, ≥40 years, based on the presence/absence of ADRD (matching by demographic and medical factors). AI/AN individuals with ADRD accrued double the costs compared to those without ADRD, costing an additional $880.45 million to $1.91 billion/year.
患有阿尔茨海默病和相关痴呆症(ADRD)的个体比没有 ADRD 的同龄人累积更高的医疗保健利用成本,但美国印第安人/阿拉斯加原住民(AI/AN)的 ADRD 增量成本尚不清楚。使用加权平均差异的基于百分位的 bootstrap 95%置信区间的基于百分比的回溯性分析了全州付费电子健康记录数据,以比较符合医疗补助和州计划条件的 AI/AN (≥40 岁)的非部落和印度卫生服务利用成本的总累积,根据是否存在 ADRD(按人口统计学和医疗因素匹配)。患有 ADRD 的 AI/AN 个体比没有 ADRD 的个体成本增加了一倍,每年额外增加 8.8045 亿美元至 19.10 亿美元。